Records containing: Hodgkin Lymphoma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2021-07-12A Phase Ib Multi-Cohort Trial of MK-3475 (Pembrolizumab) in Subjects With Hematologic Malignancies
-
CLINICAL_TRIALS study record update · 2021-07-07A Phase I Study of Pentamidine in Combination With Salvage Chemotherapy for Relapsed/Refractory Classical Hodgkin Lymphoma
-
CLINICAL_TRIALS study record update · 2021-06-24Post Transplant Infusion of Allogeneic CD8 Memory T-Cells as Consolidative Therapy After Non-myeloablative Allogeneic Hematopoietic Cell Transplantation in Patients With Leukemia and Lymphoma
-
CLINICAL_TRIALS study record update · 2021-06-11Very Low-dose Total Body Irradiation in Combination With Total Lymphoid Irradiation and Anti-Thymocyte Globulin to Improve Donor Engraftment in Patients Undergoing Non-Myeloablative Hematopoietic Cell Transplantation
-
CLINICAL_TRIALS study record update · 2021-06-08Unrelated Umbilical Cord Blood (UCB) Transplantation
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2021-05-24Phase I Study of Valproic Acid Expanded Cord Blood Stem Cells as an Allogeneic Donor Source for Adults With Hematological Malignancies
-
CLINICAL_TRIALS study record update · 2021-05-07Phase I Trial of Escalated Doses of Targeted Marrow Irradiation (TMI) Combined With Fludarabine and Busulfan as Conditioning Regimen for Allogeneic Hematopoietic Progenitor Cell Transplantation
-
CLINICAL_TRIALS study record update · 2021-04-28Cognitive Behavioral Therapy (CBT) Web-based Intervention on Fatigue in Survivors of Hodgkin Lymphoma - a Pilot Study
-
CLINICAL_TRIALS study record update · 2021-04-13A Multi-center, Non-randomized, Open-label Phase II Clinical Study on the Treatment of Newly Diagnosed Advanced Hodgkin's Lymphoma With PD-1 Antibody (Tislelizumab) Combined With AVD Regimen (Doxorubicin, Vindesine, Dacarbazine) Under the Guidance of PET/CT
-
CLINICAL_TRIALS study record update · 2021-02-15Very Early FDG-PET/CT-response Adapted Therapy for Advanced Stage Hodgkin Lymphoma, a Randomized Phase III Non-inferiority Study of the EORTC Lymphoma Group
-
CLINICAL_TRIALS study record update · 2021-01-15Anti-PD-1 Antibody Treatment With Cemiplimab and Radiotherapy in Early-stage Favorable Classical Hodgkin Lymphoma (CARHL) - A Randomized Phase II Trial
-
CLINICAL_TRIALS study record update · 2020-12-22A Phase II Study of Brentuximab Vedotin (BV) in the Treatment of Elderly Hodgkin Lymphoma (HL) Patients at First Relapse or With Primary Refractory Disease.
-
CLINICAL_TRIALS study record update · 2020-12-04Intra-osseous Co-transplant of Cord Blood and Mesenchymal Stromal Cells: A Feasibility Study
-
CLINICAL_TRIALS study record update · 2020-11-27A Multi-Center International Hospital-Based Case-Control Study of Lymphoma in Asia (AsiaLymph)
-
CLINICAL_TRIALS study record update · 2020-11-13GHSG-AFM13 An Open-label, Randomized, Multicenter Phase II Trial With AFM13 in Patients With Relapsed or Refractory Hodgkin Lymphoma
-
CLINICAL_TRIALS study record update · 2020-11-09A Phase I/Pilot Study of CPX-351 for Children, Adolescents and Young Adults With Recurrent or Refractory Hematologic Malignancies
-
CLINICAL_TRIALS study record update · 2020-11-04HD16 for Early Stages - Treatment Optimization Trial in the First-line Treatment of Early Stage Hodgkin Lymphoma; Treatment Stratification by Means of FDG-PET
-
CLINICAL_TRIALS study record update · 2020-09-16Retrospective, Multicentric, Observational Study to Evaluate the Efficacy and Safety of the Combination of an Immune Checkpoint Inhibitor (ICI) and Radiotherapy (RT) in Patients With Relapsed/Refractory (R/R) Classical Hodgkin Lymphoma (cHL)
-
CLINICAL_TRIALS study record update · 2020-09-03Developing Lung Cancer Screening in Hodgkin Lymphoma Survivors: a Qualitative Study
-
CLINICAL_TRIALS study record update · 2020-09-01Improving Sleep Quality, Psychosocial Functioning, and Cancer Related Fatigue With Light Therapy
-
CLINICAL_TRIALS study record update · 2020-08-24Brentuximab Vedotin Plus AD in Non-bulky Limited Stage Hodgkin Lymphoma
-
CLINICAL_TRIALS study record update · 2020-08-18A Randomized, Open-label, Phase 2 Trial of Chidamide+Decitabine+Camrelizumab Versus Decitabine+Camrelizumab in Anti-PD-1 Antibody Resistant Patients With Classical Hodgkin Lymphoma.
-
CLINICAL_TRIALS study record update · 2020-08-14Addition of Chidamide to the Combination Treatment of Decitabine Plus Camrelizumab in Combination Treatment Resistant/Relapsed Patients With Classical Hodgkin Lymphoma: an Open-label, Single Arm, Phase II Trial
-
CLINICAL_TRIALS study record update · 2020-08-12An Open-label, Multicenter, phase2/3 Study of Camrelizumab Plus Decitabine in Anti-PD-1 Treatment-naive Patients With Relapsed/Refractory Classical Hodgkin Lymphoma
-
CLINICAL_TRIALS study record update · 2020-07-24Adoptive Transfer of T Regulatory Cell for Suppression of Acute Graft-vs-Host-Disease After an Umbilical Cord Blood Transplant for Hematologic Malignancies